GU Cancers 2020 | Genetic risk assessment for hereditary RCC

VJOncology is committed to improving our service to you

Michael Daneshvar

Michael Daneshvar, MD, SUNY Upstate Medical Center, Syracuse, NY, discusses a report from the consensus panel on the genetic risk assessment for hereditary renal cell carcinoma (RCC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter